← Back to headlines
Moderna's Stock Surges on Cancer Vaccine Study Breakthrough
Moderna's shares have doubled in value following optimistic news regarding a potential major advancement in personalized cancer treatment, driven by a new study on a cancer vaccine.
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
orfGerman1h ago
Studie zu Krebsimpfstoff beflügelt Moderna
Read full article →index-hrSerbian1h ago
Dionice Moderne se udvostručile zbog mogućeg velikog napretka u liječenju raka
OPTIMIZAM zbog mogućeg velikog napretka u personaliziranom liječenju raka doveo je do udvostručenja vrijednosti dionica Moderne.
Read full article →Coverage Timeline
First report: index-hr · 19 Aug, 15:08|Full coverage: 2 · 8m|Window: 8m
Left-leaningCenterRight-leaning
